Literature DB >> 20661715

Pharmacological preconditioning by milrinone: memory preserving and neuroprotective effect in ischemia-reperfusion injury in mice.

Reetu Saklani1, Amteshwar Jaggi, Nirmal Singh.   

Abstract

We tested the neuroprotective effect of milrinone, a phosphodiesterase III inhibitor, in pharmacological preconditioning. Bilateral carotid artery occlusion for 12 min followed by reperfusion for 24 h produced ischemia-reperfusion (I/R) cerebral injury in male Swiss albino mice. Cerebral infarct size was measured using triphenyltetrazolium chloride staining. Memory was assessed using the Morris water maze test, and motor coordination was evaluated using the inclined beam walking test, rota-rod test, and lateral push test. Milrinone (50 microg/kg & 100 microg/kg i.v.) was administered 24 h before surgery in a separate group of animals to induce pharmacological preconditioning. I/R increased cerebral infarct size and impaired memory and motor coordination. Milrinone treatment significantly decreased cerebral infarct size and reversed I/R-induced impairments in memory and motor coordination. This neuroprotective effect was blocked by ruthenium red (3 mg/kg, s.c.), an intracellular ryanodine receptor blocker. These findings indicate that milrinone preconditioning exerts a marked neuroprotective effect on the ischemic brain, putatively due to increased intracellular calcium levels activating calcium-sensitive signal transduction cascades.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20661715     DOI: 10.1007/s12272-010-0711-6

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  9 in total

1.  Evolving possible link between PI3K and NO pathways in neuroprotective mechanism of ischemic postconditioning in mice.

Authors:  Puja Gulati; Nirmal Singh
Journal:  Mol Cell Biochem       Date:  2014-08-24       Impact factor: 3.396

2.  Protective and therapeutic effects of milrinone on acoustic trauma in rat cochlea.

Authors:  Seyit Mehmet Ceylan; Erdal Uysal; Serdar Altinay; Efe Sezgin; Nagihan Bilal; Emine Petekkaya; Mehmet Dokur; Mahmut Alper Kanmaz; Mustafa Emre Gulbagci
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-04-06       Impact factor: 2.503

Review 3.  Nitrile-containing pharmaceuticals: target, mechanism of action, and their SAR studies.

Authors:  Xi Wang; Yuanxun Wang; Xuemin Li; Zhenyang Yu; Chun Song; Yunfei Du
Journal:  RSC Med Chem       Date:  2021-08-10

4.  Neuroprotective effect of gadolinium: a stretch-activated calcium channel blocker in mouse model of ischemia-reperfusion injury.

Authors:  Puja Gulati; Arunachalam Muthuraman; Amteshwar S Jaggi; Nirmal Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-11       Impact factor: 3.000

Review 5.  Global cerebral ischemia: synaptic and cognitive dysfunction.

Authors:  Jake T Neumann; Charles H Cohan; Kunjan R Dave; Clinton B Wright; Miguel A Perez-Pinzon
Journal:  Curr Drug Targets       Date:  2013-01-01       Impact factor: 3.465

6.  Intravenous milrinone for treatment of delayed cerebral ischaemia following subarachnoid haemorrhage: a pooled systematic review.

Authors:  Mendel Castle-Kirszbaum; Leon Lai; Julian Maingard; Hamed Asadi; R Andrew Danks; Tony Goldschlager; Ronil V Chandra
Journal:  Neurosurg Rev       Date:  2021-03-08       Impact factor: 3.042

7.  Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL/6J mice.

Authors:  Yuri A Blednov; Jillian M Benavidez; Mendy Black; R Adron Harris
Journal:  Front Neurosci       Date:  2014-05-27       Impact factor: 4.677

8.  Development of a Rapid Mass Spectrometric Determination of AMP and Cyclic AMP for PDE3 Activity Study: Application and Computational Analysis for Evaluating the Effect of a Novel 2-oxo-1,2-dihydropyridine-3-carbonitrile Derivative as PDE-3 Inhibitor.

Authors:  Ilaria Cicalini; Barbara De Filippis; Nicola Gambacorta; Antonio Di Michele; Silvia Valentinuzzi; Alessandra Ammazzalorso; Alice Della Valle; Rosa Amoroso; Orazio Nicolotti; Piero Del Boccio; Letizia Giampietro
Journal:  Molecules       Date:  2020-04-15       Impact factor: 4.411

9.  Milrinone Ameliorates the Neuroinflammation and Memory Function of Alzheimer's Disease in an APP/PS1 Mouse Model.

Authors:  Qingyou Chen; Yue Yin; Li Li; Yanjiao Zhang; Wei He; Yan Shi
Journal:  Neuropsychiatr Dis Treat       Date:  2021-06-30       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.